Amendment to the Basic Agreement of June 17/th//18/th/ 1999
between
LION bioscience XX
Xxxxxxxxxxxx. 00,
00000 Xxxxxxxxxx, Xxxxxxx
represented by its managing board
-called "LION" hereinafter-
and
Xxxxx XX
51368 Leverkusen
-called "BAYER" hereinafter-
Due to the successful co-operation of LION and BAYER during the first 2 years of
the contractual period the parties agree to amend the Basic Agreement of June
17/th//18/th/ 1999 as follows:
As the delivery of human or rat genes encoding for druggable or therapeutic
proteins was realized in a much faster sequence than originally provided in
Annex 1.9, in addition to the term 8 of the Basic Agreement BAYER agrees to pay
to LION a one time success premium of US $2.310.000.
All other provisions of the Basic Agreement remain in force without
modification.
In Witness thereof, the parties hereof, intending to be bound hereby, have
signed this Amendment as of the dates indicated here:
Executed by and on behalf of LION bioscience AG
Heidelberg, 15.2.2002
/s/ Xxxxxxxxx xxx Xxxxxx und Xxxxxxx
---------------------------------------
Xx. Xxxxxxxxx xxx Xxxxxx und Xxxxxxx
Executed by and on behalf of Xxxxx XX
Leverkusen,
/s/ Xxxxxxxx Xxxxxxx
---------------------------------------
Prof. Xx. Xxxxxxxx Xxxxxxx
